NIH-funded research R01 grant

Exploring how nanomaterials can enhance vaccine responses

Official title: Mechanisms of Nanomaterials-based Combination Adjuvants

Funded at Washington University · NIH-10992674 · Data updated 2026-11-12

This study is looking at how special tiny fibers can help vaccines work better by boosting the immune response, which could lead to more effective vaccines for everyone.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startDecember 5, 2022
Project endNovember 30, 2026
Funding year2025
Award (this year)$475,300
NIH project number5R01AI168918-03
Project IDNIH-10992674 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are receiving vaccinations or are at risk of infections that vaccines aim to prevent.

Less likely to help

Patients who are not receiving vaccinations or have contraindications to vaccination may not benefit from this research.

What this research studies

This research investigates the use of self-assembling peptide nanofibers as vaccine adjuvants to improve immune responses. By carefully selecting combinations of these nanofibers with specific molecular agonists, the study aims to enhance the effectiveness of vaccines. The approach focuses on understanding the mechanisms by which these nanofibers and agonists interact with the immune system, particularly in promoting innate immune signaling without causing unwanted side effects. Patients may benefit from more effective vaccines that provide better protection against diseases.

Why it matters

Potential benefit: If successful, this research could lead to more effective vaccines that enhance immune responses and provide better protection against infections.

How similar studies have gone: Other research has shown promising results with similar approaches using nanomaterials in vaccine adjuvants, indicating potential for success in this area.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Rudra, Jai — Washington University
  • Study coordinator: Rudra, Jai

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.